🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. HMB-002 (Part A)

    Hemab Therapeutics Holdings

    Von Willebrand Disease (VWD)

    phase 2 small molecule active

    1 trial

  2. HPV DNA Plasmids Therapeutic Vaccine VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Anal Intraepithelial Neoplasia

    phase 2 mab completed

    1 trial

  3. HT-001 2% Topical Gel

    Hoth Therapeutics

    Acneiform Eruption Due to Chemical

    phase 2 small molecule active

    1 trial

  4. HT-001, HT-001, The corresponding placebo is formulated using the same excipients as HT-001 and is identical in color and physical appearance., HT-001

    Hoth Therapeutics

    Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors

    phase 2 small molecule active

    1 trial

  5. HTNV/PUUV DNA vaccine

    United Therapeutics Europe Ltd

    Hemorrhagic Fever With Renal Syndrome

    phase 2 mab completed

    1 trial

  6. HTX-011A

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  7. HTX-011B

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  8. HTX-034

    Heron Therapeutics

    Bunions

    phase 2 small molecule completed

    1 trial

  9. HUMSCs combined with bovine type I collagen

    The First People's Hospital of Lianyungang

    Burn Wounds

    phase 2 other active

    1 trial

  10. HYCAMTIN 4 mg powder for concentrate for solution for infusion, TAXOL 6 mg/ml, concentrato per soluzione per infusione., Neulasta 6 mg solution for injection, Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion, GEMZAR 1000 mg, poudre pour solution pour perfusion

    SUTRO BIOPHARMA, INC.

    Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)

    phase 2 small molecule active

    1 trial

  11. HYDROXYCARBAMIDE , BEVACIZUMAB , SUNITINIB , OCTREOTIDE , EVEROLIMUS , Lutathera 370 MBq/mL solution for infusion

    Ningbo Cancer Hospital

    Recurrent Meningioma without local treatment options (Surgery or Radiotherapy)

    phase 2 small molecule active

    1 trial

  12. Halneuron

    Dogwood Therapeutics

    Chemotherapy Induced Neuropathic Pain

    phase 2 small molecule active

    1 trial

  13. Heparin and Rivaroxaban

    The First People's Hospital of Lianyungang

    Liver Cirrhosis

    phase 2 small molecule completed

    1 trial

  14. Herombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chemotherapy-induced Thrombocytopenia

    phase 2 small molecule active

    1 trial

  15. Herzuma

    Vera Therapeutics

    HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study

    phase 2 small molecule active

    1 trial

  16. Hexyon suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)., MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine, RotaTeq oral solution Rotavirus vaccine (live), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), MenPenta SD, Prevenar 13 suspension for in

    Sanofi-aventis Healthcare Pty Ltd

    Meningococcal immunization

    phase 2 small molecule active

    1 trial

  17. HiPSC-RPE cells

    The First People's Hospital of Lianyungang

    AMD - Age-Related Macular Degeneration

    phase 2 mab active

    1 trial

  18. High Dose SAB-142

    SAB Biotherapeutics

    Type 1 Diabetes

    phase 2 small molecule active

    1 trial

  19. High-Low Dose Radiotherapy

    Jian Li

    Nasopharyngeal Carcinoma (NPC)

    phase 2 other active

    1 trial

  20. Humalog

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  21. Humalog

    HALOZYME THERAPEUTICS, INC.

    Diabetes Mellitus, Type 2

    phase 2 small molecule completed

    1 trial

  22. Human Adipose-Derived Stem Cell Exosomes

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 2 mab active

    1 trial

  23. Human Mesenchymal Stromal Cells

    United Therapeutics Europe Ltd

    Respiratory Distress Syndrome, Adult

    phase 2 mab completed

    1 trial

  24. Human Umbilical Cord derived MSCs

    CytoMed Therapeutics Ltd

    Lupus Nephritis

    phase 2 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources